share_log

SVB Leerink Downgrades Molecular Partners to Market Perform, Lowers Price Target to $8

Benzinga Real-time News ·  Aug 29, 2022 04:44

SVB Leerink analyst Daina Graybosch downgrades Molecular Partners (NASDAQ:MOLN) from Outperform to Market Perform and lowers the price target from $30 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment